Background
==========

Cardiovascular diseases (CVDs) are major contributors to human morbidity and mortality worldwide \[[@b1-medscimonit-25-5375]\]. Therefore, investigating the molecular mechanisms resulting in CVDs and discovering novel therapeutic agents have been the focus of research for many years \[[@b2-medscimonit-25-5375]\]. It is well known that cardiac fibrosis is an important and common pathophysiological process in many cardiovascular diseases. Extensive cardiac fibrosis leads to increased ventricular stiffness, myocardial diastolic and systolic dysfunction, and ventricular arrhythmia, eventually resulting in heart failure and subsequent sudden death \[[@b3-medscimonit-25-5375],[@b4-medscimonit-25-5375]\]. Cardiac fibroblasts (CFBs) play a critical part in the pathophysiology of cardiac fibrosis. Under pathological conditions, CFBs are activated by differentiation, migration, and proliferation \[[@b5-medscimonit-25-5375]\]. Fibroblasts differentiated into myofibroblasts which characteristically express α-smooth muscle actin (α-SMA), secreted excessive extracellular matrix (ECM) proteins such as Collagen I, Collagen III, and fibronectin, and profibrotic factors such as connective tissue growth factor (CTGF). The imbalance between collagen synthesis and degradation in the ECM, which can lead to expansion of collagens, eventually results in myocardial fibrosis \[[@b6-medscimonit-25-5375]--[@b8-medscimonit-25-5375]\]. Therefore, it is critical to search for novel drugs that can suppress CFBs transdifferentiation and proliferation for prevention and clinical cure of cardiac fibrosis.

Emerging evidence shows that aldosterone (ALD), as an end signal molecule of the renin-angiotensin-aldosterone system, promotes ECM proteins expression, inducing fibrosis and participating in cardiac remodeling \[[@b9-medscimonit-25-5375]\]. Specific binding of aldosterone with mineralocorticoid receptor (MR) promotes the progression of inflammation and cardiac fibrosis \[[@b10-medscimonit-25-5375]\]. It is well known that excess oxidative stress and inflammation aggravate cardiac fibrosis \[[@b11-medscimonit-25-5375],[@b12-medscimonit-25-5375]\]. Oxidative stress is a state characterized by dramatic generation of ROS relative to endogenous antioxidant ability. Abundant ROS production leads to ECM remodeling by irritating CFBs proliferation and activating matrix metalloproteinases (MMPs) \[[@b13-medscimonit-25-5375]\]. Recently, nuclear factor-erythroid-2 (NF-E2-) related factor 2 (Nrf2) has been widely reported to be the main regulator of antioxidant response elements. Normally, Nrf2 is bound to Kelch-Like ECH-Associated Protein 1 (Keap1) in the cytoplasm. Nrf2 is separated from Keapl after ROS production and is transferred into nucleus-bound antioxidant response elements (AREs), which initiate the transcription of heme oxygenase-1 (HO-1), and superoxide dismutase (SOD) inhibits the production of ROS \[[@b14-medscimonit-25-5375],[@b15-medscimonit-25-5375]\].

Oxymatrine (OMT), a quinolizidine alkaloid derived from the traditional Chinese herb *Radix Sophorae flavescentis*, exhibits various pharmacological activities \[[@b16-medscimonit-25-5375]\], such as anti-tumor \[[@b17-medscimonit-25-5375]\], anti-inflammation \[[@b18-medscimonit-25-5375]\], anti-fibrosis \[[@b19-medscimonit-25-5375]\], and cardio-protection action \[[@b20-medscimonit-25-5375]\]. Previous data proved that OMT attenuates inflammation and renal fibrosis, probably via blocking the TGF-β/Smad3 and NF-κB p65 pathways. OMT significantly reduces fibronectin and collagen I expression \[[@b21-medscimonit-25-5375]\]. OMT can attenuate CCl~4~-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways \[[@b22-medscimonit-25-5375]\]. Furthermore, recent evidence revealed that OMT can suppress the transdifferentiation and proliferation of CFBs induced by TGF-β \[[@b3-medscimonit-25-5375],[@b5-medscimonit-25-5375]\]. In summary, there is abundant evidence suggesting that OMT has potential inhibitory effects on cardiac fibrosis.

It is well known that ALD is a strongly induced myocardial fibrosis factor in the heart. Here, we investigated the effect of OMT on the anti-fibrosis effect induced by ALD and explore its potential mechanism via Nrf2 signaling.

Material and Methods
====================

Ethics statement
----------------

All animal experiments conformed to the Guide for the Care and Use of Laboratory Animals published by Guizhou Medical University and were approved by the Committee for Experimental Animal Ethics of Guizhou Medical University \[No. 1503068\].

Materials and reagents
----------------------

OMT (purity, 98%) was purchased from Nanjing Guangrun Biotechnology Co., Nanjing, China. ALD (purity, 95%) and curcumin (purity, 98%) were from Sigma, USA. Spironolactone (purity, 99%) was purchased from Jinglai Biological, China. Dulbecco's modified Eagle's medium (DMEM) was purchased from GIBCO (Gaithersburg, USA). Malondialdehyde (MDA), Glutathione (GSH), Superoxide dismutase (SOD), and Hydroxyproline commercial kits were purchased from Jiancheng Bioengineering (Nanjing, China). Cell Cycle Detection kits were obtained from KeyGEN BioTECH (Nanjing, China). Vimentin, Collagen I, Nrf2, Keap1, HO-1, α-SMA, Fibronectin, Tubulin, LaminB1, MR, and GAPDH antibodies were obtained from Proteintech, USA. Collagen III and CTGF antibodies were purchased from Medical Discovery Leader, China. Nrf2-siRNA was purchased from GenePharma Shanghai, China. Reactive oxygen species (ROS) Assay kits were obtained from Yeasen Biotech Co., Shanghai, China.

Culture and treatment of primary cardiac fibroblasts (CFBs)
-----------------------------------------------------------

CFBs were isolated and purified from cardiac tissues of 1- to 2-days-old Sprague-Dawley rats using continuous enzyme digestion with 0.08% trypsin, and were plated on culture flasks, as previously described \[[@b2-medscimonit-25-5375],[@b5-medscimonit-25-5375]\]. Briefly, the enzymatically separated cells were suspended in DMEM containing 12% fetal bovine serum (FBS), plated on culture flasks, harvested, and purified by 90-min differential adherence. The primary CFBs were cultured with DMEM containing 12% fetal bovine serum at 37°C in an atmosphere of 5% CO~2~. The second-passage CFBs were used for subsequent experiments. The purity of cultured CFBs was assessed through immunocytochemistry staining using mouse monoclonal vimentin antibody. The CFBs were cultured to approximately 80% confluence, and then incubated in serum-free DMEM for 24 h. Cultured CFBs were exposed to aldosterone (0.1 μmol/L) alone for 24 h, or pre-incubated with curcumin (10 μmol/L), Spironolactone (Spiro) (1 μmol/L), OMT-L (18.9 μmol/L), and OMT-H (37.8 μmol/L) for 2 h, then exposed to ALD treatment for 24 h.

CFBs proliferation assay
------------------------

MTT (5 mg/mL) was added into 96-well plates in the dark at designated experimental timepoints. After incubation for 4 h at 37°C in a 5% CO~2~ incubator, the formazan crystals were dissolved in 150 μL DMSO, and then the absorbance values were detected at 490 nm by using a microplate reader (ELX800; General Electric, Fairfield, CT).

Giemsa staining
---------------

At the designated timepoints, cells were fixed with 4% paraformaldehyde for 20 min, and then washed 3 times with PBS, stained with Giemsa dye (Baso Bioscience) A and B for 10 min, and the cellular morphology was imaged using a microscope.

Immunofluorescence staining
---------------------------

The CFBs were plated on 24-well plates. At the designated timepoints, cells were fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.5% Triton X-100 for 20 min, blocked in 7.5% goat serum for 1 h at room temperature, and then CFBs were incubated with a rabbit polyclonal anti-α-SMA primary antibody (1: 50 dilution) at 4°C overnight. Next, (FITC-conjugated goat anti-rabbit IgG, 1: 100 dilution) antibodies were incubated for 1 h at room temperature and counterstained with DAPI (5 mg/mL) for 10 min. All images were captured using a fluorescence microscope (Nikon Corporation, Tokyo, Japan).

Scratch experiment
------------------

The migration capacity of CFBs was evaluated by scratch assay as previously described \[[@b2-medscimonit-25-5375],[@b5-medscimonit-25-5375]\]. Briefly, The CFBs were plated on 6-well plates and grown to about 90% confluence. An artificial gap was generated by scratching with a sterile pipette tip. The width of the gap was measured at 24 h intervals.

Hydroxyproline colorimetric assay
---------------------------------

The level of hydroxyproline (Hyp) in supernatant of CFBs was determined using a commercial Hyp detection kit. OD values of samples were detected by microplate reader, and then the level of Hyp was calculated in accordance with the manufacturer's instructions.

Cell cycle assay
----------------

Cell cycle was assayed using flow cytometry. The CFBs was collected after treatment and fixed overnight with 70% ethanol at 4°C, according to the manufacturer's protocols, and the results were assessed using ACEA NovoCyte. Data were analyzed using NovoExpress software.

Transfection of CFBs with Nrf2 siRNA
------------------------------------

The sequence of the rat Nrf2 siRNA was 5′-GCAGCAUACAGCAG GACAUTT-3′, and its complementary strand was 5′-AUGUCCUGCUGU AUGCUGCTT-3′. According to the manufacturer's instructions, the CFBs were transfected with 50 nM Nrf2-siRNA or negative control siRNA (NC) with Lipofectamine 2000 (Invitrogen) for 24 h. Transfected cells were subjected to ALD alone for 24 h, or pre-incubation with OMT for 2 h before being subjected to ALD for 24 h. Western blot analysis was performed to assess the silencing effect.

Measurement of intracellular reactive oxygen species in CFBs
------------------------------------------------------------

The level of intracellular reactive oxygen species (ROS) was measured with 2′,7′-dichlorofluorescin diacetate (DCFH-DA). Briefly, after different treatments, CFBs were incubated with 10 μM DCFH-DA for 30 min at 37°C. Then, intracellular ROS was detected by immunofluorescence microscope and the OD value was also checked by fluorometer (VLBL0TD2, Thermo Fisher Scientific, Vantaa, Finland).

Measurement of the levels of malondialdehyde (MDA) and glutathione (GSH), and superoxide dismutase (SOD) activity
-----------------------------------------------------------------------------------------------------------------

The levels of intracellular MDA and GSH, and SOD activity in CFBs were detected by MDA, SOD, and GSH commercial kits, according to the manufacturer's protocols. The results were calculated according to the manufacturer's instructions.

Western blot analysis
---------------------

At the designated timepoints, CFBs protein was extracted using RIPA buffer with protease and phosphatase inhibitors. The nuclear and cytoplasmic protein was extracted using nuclear and cytoplasmic protein extraction kits (Bestbio Institute of Biotechnology), according to the manufacturer's protocols. The BCA protein detection kit was used to measure the protein concentration. Equivalent amounts of protein samples (20--30 μg) were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on an 8% gel and subsequently transferred to polyvinylidene difluoride (PVDF) membranes at 4°C, then blocked with 5% non-fat milk in TBST at room temperature for 2 h. The membranes were incubated with the following primary antibody at 4°C overnight: α-SMA (14395-1-AP, Proteintech, 1: 1000), Fibronectin (66042-1-lg, Proteintech, 1: 5000), CTGF (MD5912-50, Medical Discovery Leader, 1: 1000), Collagen III (MD4405-50, Medical Discovery Leader, 1: 1000), HO-1(66743-1-lg, Proteintech, 1: 1000), and Nrf2 (16396-1-AP, Proteintech, 1: 1000), Keap1(10503-2-AP, Proteintech, 1: 1000), collagen I (14695-1-AP, Proteintech, 1: 1000), MR (21854-1-AP, Proteintech, 1: 1000), LaminB1 (12987-1-AP, Proteintech, 1: 1000), Tubulin (10094-1-AP, Proteintech, 1: 10,000) and GAPDH (60004-1-lg, Proteintech, 1: 10000). After washing the membranes 3 times with 1×TBST, the membranes were incubated for 1.5 h at room temperature with Anti-mouse IgG (1: 10 000, PMK-014-095) and Anti-rabbit IgG (1: 10 000, PMK-014-090). The antigen-antibody complexes were detected by enhanced chemiluminescence (ECL, 7Sea Biotechnology, Shanghai, China). Bands were scanned and quantified using Syngene Gel Imaging System (Bio-Rad) analysis software.

RNA extraction and quantitative real-time polymerase chain reaction (qRT-PCR)
-----------------------------------------------------------------------------

Total cellular RNA was extracted from CFBs using the E.Z.N.A.^®^ Total RNA kit I (R6834-01, OMEGA) according to the manufacturer's instructions. RNA was reverse-transcribed into cDNA using the PrimeScript™ RT reagent kit (RR037A, Takara Bio, Inc.). Quantitative real-time PCR was performed on cDNA using SYBR^®^ Premix Ex Taq™ II (Takara Bio, Inc.) and the CFX Manager 3.0 Real-Time PCR System (Bio-Rad). GAPDH was used as the internal control for mRNA expression. The specific primers used were as follows: rat Nrf2 forward, 5′-GCCTTCCTCTGCTGCCATTAGTC-3′, and reverse, 5′-TCATTGAACTCCACCGTGCCTTC-3′; rat GAPDH, forward, 5′-GACATGCCGCCTGGAGAAAC-3, reverse, 5′-AGCCCAGGATGCCCTTTAGT-3′.

Statistical analysis
--------------------

All data are expressed as the mean ±SEM. All data analysis was performed using GraphPad prism^®^ 6.0 software (La Jolla, CA). Statistical analysis was performed using one- or two-way ANOVA for multiple comparisons and the *t* test for 2 groups. A value of P\<0.05 was considered to be statistically significant. Data were derived from at least 3 independent experiments.

Results
=======

OMT inhibits proliferation in CFBs subjected to ALD
---------------------------------------------------

The primary CFBs were mostly thin and triangular-shaped, as shown by use of an inverted microscope ([Figure 1A](#f1-medscimonit-25-5375){ref-type="fig"}). Vimentin, the specific biomarker of mesenchymal cells, was used to identify CFBs. The purity of cultured CFBs was more than 95% by immunocytochemistry ([Figure 1B, 1C](#f1-medscimonit-25-5375){ref-type="fig"}). The OMT chemical structure is shown in [Figure 1D](#f1-medscimonit-25-5375){ref-type="fig"}. The concentrations of ALD, OMT, and spironolactone were determined by MTT assay and previous data. CFBs were treated with different concentrations of ALD (0.001--1 μmol/L) for 24 h. The results showed that 0.1 μmol/L ALD significantly promoted cell proliferation ([Figure 1E](#f1-medscimonit-25-5375){ref-type="fig"}). Then, CFBs were pre-incubated with various concentrations of OMT (4.73--189.1μmol/L) and spironolactone (0.01--10 μmol/L) for 2 h before being subjected to ALD for 24 h. The results showed that OMT (18.9 μmol/L, 37.8 μmol/L) and spironolactone (1 μmol/L) inhibited ALD-induced cell proliferation of CFBs ([Figure 1F, 1G](#f1-medscimonit-25-5375){ref-type="fig"}), in agreement with previous reports \[[@b5-medscimonit-25-5375],[@b23-medscimonit-25-5375]\]. [Figure 1H](#f1-medscimonit-25-5375){ref-type="fig"} shows that, compared to the control group, ALD significantly increased CFBs proliferation. Pre-incubated with OMT, the MR antagonist spironolactone, and the Nrf2 agonist curcumin inhibited this proliferation effect displayed by MTT. ALD exposure remarkably increased the number of CFBs compared to the control group, which was attenuated by pre-incubation with OMT, spironolactone, and curcumin ([Figure 1I](#f1-medscimonit-25-5375){ref-type="fig"}) as shown by Giemsa staining. Taken together, these data suggest that OMT and curcumin can ameliorate ALD-induced CFBs proliferation.

Effect of OMT on the cell cycle and migration ability of CFBs induced by ALD
----------------------------------------------------------------------------

After exposure of CFBs to ALD, S phase was significantly increased compared to the control group. Pretreatment with OMT, spironolactone, and curcumin inhibited the number of cells in S phase of the cell cycle following ALD stimulation ([Figure 2A, 2B](#f2-medscimonit-25-5375){ref-type="fig"}). As shown in [Figure 2C and 2D](#f2-medscimonit-25-5375){ref-type="fig"}, the scratch results showed that ALD exposure enhanced migration ability of CFBs. Pre-incubation with OMT, spironolactone, and curcumin significantly alleviated the migration ability of CFBs induced by ALD ([Figure 2C, 2D](#f2-medscimonit-25-5375){ref-type="fig"}).

OMT inhibited ALD-induced hydroxyproline (Hyp) secretion and Collagen I, Collagen III, FN, α-SMA, CTGF, and MR expression of CFBs
---------------------------------------------------------------------------------------------------------------------------------

Hydroxyproline (Hyp), a biomarker of collagen secretion, is a degradation product of collagen. After exposure to ALD, the Hyp content was significantly increased in medium. OMT, spironolactone, and curcumin significantly alleviated the ALD-induced Hyp secretion ([Figure 3A](#f3-medscimonit-25-5375){ref-type="fig"}). The expression levels of fibrosis-associated proteins of Collagen I, Collagen III, FN, α-SMA, CTGF, and MR were remarkably increased induced by ALD compared to the control group ([Figure 3B--3H](#f3-medscimonit-25-5375){ref-type="fig"}). OMT attenuated the proteins of ALD-induced Collagen I, Collagen III, FN, α-SMA, CTGF, and MR, as well as spironolactone and curcumin ([Figure 3B--3H](#f3-medscimonit-25-5375){ref-type="fig"}). A similar trend was confirmed in immunofluorescent staining for α-SMA by fluorescence microscopy ([Figure 3I](#f3-medscimonit-25-5375){ref-type="fig"}).

OMT ameliorated ALD-induced cardiac fibrosis via activating the Nrf2/Keap1 pathway
----------------------------------------------------------------------------------

The protein of Nrf2 and Keap1 in cytoplasm expression contents were remarkably increased in the ALD group as shown by Western blot assay ([Figure 4B, 4C](#f4-medscimonit-25-5375){ref-type="fig"}). OMT, spironolactone, and curcumin attenuated the protein levels of ALD-induced Nrf2 and Keap1 protein in cytoplasm ([Figure 4B, 4C](#f4-medscimonit-25-5375){ref-type="fig"}). After exposing CFBs to ALD, the expression of Nrf2 in the nucleus and HO-1 were significantly decreased compared with the control group ([Figure 4A, 4D](#f4-medscimonit-25-5375){ref-type="fig"}), which were reversed by OMT, spironolactone, and curcumin ([Figure 4A, 4D](#f4-medscimonit-25-5375){ref-type="fig"}). The Nrf2 protein in cytoplasm, Keap1 in cytoplasm, HO-1, and Nrf2 in the nucleus exhibited no significant difference between the curcumin group and the OMT + curcumin group ([Figure 4A--4D](#f4-medscimonit-25-5375){ref-type="fig"}). Furthermore, pretreatment with OMT, spironolactone, and curcumin also increased the ALD reduced Nrf2 mRNA expression ([Figure 4E](#f4-medscimonit-25-5375){ref-type="fig"}).

As shown in [Figure 5A, 5B](#f5-medscimonit-25-5375){ref-type="fig"}, the transfection efficiency of Nrf2 siRNA was more than 60%. OMT significantly decreased ALD-induced upregulation of α-SMA, a common biomarker for fibroblast-to-myoblast transdifferentiation. However, the ameliorated effect of OMT was reversed by Nrf2 siRNA. The α-SMA protein expression exhibited no significant difference between the Nrf2 siRNA groups and OMT+Nrf2 siRNA groups ([Figure 5C, 5D](#f5-medscimonit-25-5375){ref-type="fig"}), which means that OMT depends on the Nrf2 signal pathway. A similar trend was confirmed in immunofluorescent staining for α-SMA by fluorescence microscopy ([Figure 5H](#f5-medscimonit-25-5375){ref-type="fig"}). As shown in [Figure 5E--s5G](#f5-medscimonit-25-5375){ref-type="fig"}, the results illustrated that the upregulated levels of CTGF, collagen I, and collagen III induced by ALD exposure were significantly decreased by OMT, and Nrf2 siRNA abolished this trend. The collagen I, collagen III, and CTGF protein expression exhibited no significant difference between the Nrf2 siRNA groups and the OMT+Nrf2 siRNA groups ([Figure 5E--s5G](#f5-medscimonit-25-5375){ref-type="fig"}).

OMT inhibits oxidative stress levels in CFBs induced by ALD
-----------------------------------------------------------

It is well known that oxidant stress participates in the activation of CFBs and differentiation of CFBs into myofibroblasts. In the present study, ROS contents were detected by fluorescent probe DCFH-DA and we also detected the relative fluorescence intensity (OD value). As shown in [Figure 6A, 6B](#f6-medscimonit-25-5375){ref-type="fig"}, the relative fluorescence intensity of ROS increased significantly after CFBs were exposed to ALD. Pretreatment with OMT, spironolactone, and curcumin decreased the relative fluorescence intensity of ALD-induced ROS, as well ROS scavenger N-acetylcysteine (NAC). Furthermore, malondialdehyde (MDA) is widely used as an oxidative stress marker. glutathione (GSH) and superoxide dismutase (SOD) protect cells from ROS damage as ROS scavengers. As shown in [Figure 6C--6E](#f6-medscimonit-25-5375){ref-type="fig"}, ALD exposed to CFBs, the level of MDA was significantly increased compared with the control group, and the GSH and SOD activity of CFBs was significantly decreased by ALD stimulation. Pretreatment with OMT, spironolactone, and curcumin significantly decreased the ALD-induced MDA increase and enhanced the ALD-reduced GSH level and SOD activity.

Discussion
==========

We showed that OMT, MR antagonist spironolactone, and Nrf2 agonist curcumin can ameliorate transdifferentiation of cardiac fibroblasts to myofibroblasts induced by ALD*in vitro*. In CFBs exposed to ALD, OMT inhibited cardiac fibroblast-to-myoblast transformation and collagen production (collagen I and collagen III) in an Nrf2-dependent manner. Moreover, OMT, MR antagonist spironolactone, and Nrf2 agonist curcumin reduced ROS generation and MDA production, and increased anti-oxidative GSH levels and SOD activity. Furthermore, similar to curcumin, OMT activated and accelerated the translocation of Nrf2 to the nucleus.

Pathological cardiac fibrosis is involved in almost all the pathophysiological processes of cardiovascular diseases. Finding novel molecular targets to inhibit cardiac fibrosis in humans has been an important research focus. The main pathological characteristics of cardiac fibrosis are transdifferentiation, which enhances proliferation and myofibroblast differentiation of CFBs, and excessive ECM accumulation \[[@b24-medscimonit-25-5375]--[@b26-medscimonit-25-5375]\]. Aldosterone is a pivotal fibrosis factor of the renin-angiotensin-aldosterone system, which deteriorates cardiac oxidative stress and cardiac fibrosis, as well as activating MR. Increasing data suggest that MR activation exacerbates the pro-inflammatory/fibrotic effects of AngII-AT1R signaling by increasing cardiac oxidative stress. MR antagonists such as spironolactone have beneficial influences on cardiac remodeling and oxidative stress \[[@b27-medscimonit-25-5375]\]. Studies have shown that amelioration of cardiac fibrosis in diabetic rats was possible through inhibiting oxidative stress \[[@b28-medscimonit-25-5375]\]. Nrf2 is an antioxidant and a crucial factor in reducing oxidative stress \[[@b29-medscimonit-25-5375]\]. Furthermore, Nrf2 knockdown abolished curcumin-alleviating CCl~4~-induced hepatic fibrosis. Curcumin activates Nrf2 and promotes the translocation of Nrf2 to the nucleus and attenuates hepatic fibrosis \[[@b30-medscimonit-25-5375]\]. We previously reported that OMT inhibits CFBs proliferation, differentiation, migration, and extracellular matrix secretion \[[@b3-medscimonit-25-5375],[@b5-medscimonit-25-5375],[@b19-medscimonit-25-5375]\] and ameliorates myocardial fibrosis induced by acute myocardial infarction in rats \[[@b31-medscimonit-25-5375]\]. OMT ameliorates hepatic fibrosis induced by thioacetamide \[[@b32-medscimonit-25-5375]\] and also inhibits oxidative stress \[[@b33-medscimonit-25-5375]\]. OMT inhibits collagen synthesis in keloid fibroblasts and ameliorates bleomycin-induced lung fibrosis \[[@b34-medscimonit-25-5375],[@b35-medscimonit-25-5375]\]. In the present study, we found that CFBs exposed to ALD induced proliferation and myofibroblast differentiation of CFBs, and then the Nrf2 agonists curcumin, Nrf2 siRNA, and OMT were used to evaluate changes.

The differentiation, proliferation, migration, and collagen deposition of fibroblasts play key roles in fibrosis \[[@b36-medscimonit-25-5375],[@b37-medscimonit-25-5375]\]. In CFBs exposed to ALD, the proliferation and migration ability was significantly increased, whereas pretreatment with OMT, MR antagonist spironolactone, and Nrf2 agonist curcumin attenuated proliferation and migration ability. Furthermore, OMT and curcumin reduced the number of fibroblasts in S phase of the cell cycle following ALD stimulation, which is similar to the effect of spironolactone, a competitive antagonist of aldosterone. OMT intervention and activation of Nrf2 signaling inhibits CFBs proliferation by cell cycle arrest and migration.

The proliferation of CFBs and excessive ECM accumulation are the predominant pathological characteristics of cardiac fibrosis. In addition, collagen III, collagen I, and FN are the main ECM proteins, α-SMA is a hallmark of myofibroblast differentiation, and CTGF is a crucial pro-fibrotic factor \[[@b2-medscimonit-25-5375],[@b38-medscimonit-25-5375],[@b39-medscimonit-25-5375]\]. Our results showed that ALD stimulation remarkably increased the levels of collagen I, collagen III, CTGF, FN, α-SMA, and MR expression, which were significantly depressed by pretreatment with OMT, spironolactone, and curcumin. Hyp, the decomposition product of collagen, is considered to be a biomarker of collagen quantity, which was quantified to evaluate the degree of cardiac fibrosis \[[@b40-medscimonit-25-5375],[@b41-medscimonit-25-5375]\]. In CFBs exposed to ALD, the Hyp content was significantly increased in medium, whereas pre-incubation with OMT, spironolactone, and curcumin depressed the content. OMT, blockade of the MR, and activation of Nrf2 signaling can inhibit transdifferentiation of CFBs to myofibroblasts and collagen deposition, attenuating cardiac fibrosis induced by ALD.

Oxidative stress can promote the development of cardiac fibrosis, and the antioxidant N-acetylcysteine can attenuate cardiac fibrosis and heart failure in mice, possibly by reducing oxidative stress \[[@b42-medscimonit-25-5375],[@b43-medscimonit-25-5375]\]. In the present study, OMT, spironolactone, and curcumin downregulated levels of ROS and MDA and upregulated levels of GSH and SOD activity in CFBs induced by ALD. Our data indicate that Nrf2 participates in the antioxidant effects of OMT, and the anti-fibrotic effect of OMT might occur by decreasing oxidative stress levels and promoting anti-oxidative GSH and SOD activity. Nrf2 is the key regulator of the antioxidant response and anti-fibrotic effects \[[@b44-medscimonit-25-5375]\]. Our results suggest that ALD promotes the protein expression of Nrf2 and Keap1 in cytoplasm, and decreases Nrf2 in the nucleus and HO-1 in CFBs, and these effects were reversed by OMT, spironolactone, and curcumin. OMT suppresses ALD-induced CFBs transdifferentiation and is related to the Nrf2/Keap1 signaling pathway. There was no significant difference in protein expression between the curcumin groups and the OMT+curcumin treated group, and qRT-PCR results show that pre-incubation with OMT, spironolactone, and curcumin increases the ALD-induced reduce the mRNA expression of Nrf2. These findings suggest that similar to the effects of curcumin, OMT activated and enhanced the expression of Nrf2 in the nucleus. Furthermore, we confirmed that the upregulated levels of collagen I, collagen III, α-SMA, and CTGF induced by ALD were significantly decreased by OMT, and Nrf2 siRNA abolished this reduction. Our results indicate that the anti-fibrotic effects of OMT on CFBs were Nrf2-dependent. Thus, OMT activates Nrf2 signaling, reducing cardiac fibrosis through the Nrf2 signal pathway.

Conclusions
===========

We investigated the OMT, activation of Nrf2 signaling, and inhibition of MR, which can suppress collagen synthesis, CFBs proliferation, and differentiation induced by ALD. OMT exerts anti-fibrotic effects by activating Nrf2 signaling, suggesting that OMT prevents cardiac fibrosis and may be a potential therapeutic agent.
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![OMT and curcumin inhibit ALD-induced proliferation in CFBs. (**A**) Morphology image of the primary CFBs (magnification, 50×). (**B**) Representative image of negative control stained cells (PBS was used instead of primary antibody, magnification, 200×). (**C**) Representative image of cells stained with the anti-vimentin antibody (magnification, 200×). (**D**) The OMT chemical structure. (**E**) Effects of various concentrations of ALD (0.001--1 μmol/L) on proliferation of CFBs. (**F**) Effects of various concentrations of OMT (4.73--189.1 μmol/L) on ALD-induced proliferation of CFBs. (**G**) Effects of various concentrations of spironolactone (0.01--10μmol/L) on ALD-induced proliferation of CFBs. (**H**) CFBs were pretreated with 10 μmol/L curcumin, 1 μmol/L spironolactone (Spiro), 18.9 μmol/L OMT, or 37.8 μmol/L OMT for 2 h, and then exposed to 0.1 μmol/L ALD for 24 h. The MTT assay was used to measure cell viability. (**I**) CFBs morphological change revealed by Giemsa staining analysis. Cytoplasm was stained pink and nucleus stained violet (magnification, 200×). Results are presented as the mean ±SEM (\* p\<0.05 and \*\* p\<0.01 *vs.* control; ^\#^ p\<0.05 and ^\#\#^ p\<0.01 *vs.* ALD).](medscimonit-25-5375-g001){#f1-medscimonit-25-5375}

![Effect of OMT and curcumin on the cell cycle and migration ability of CFBs induced by ALD. CFBs were pretreated with 10 μmol/L curcumin, 1 μmol/L spironolactone (Spiro), 18.9 μmol/L OMT, or 37.8 μmol/L OMT for 2 h, and then exposed to 0.1 μmol/L ALD for 24 h. (**A, B**) Flow cytometry was used to assess cell cycle. (**C, D**) Quantification of the width of cell migration after scratch test. Results are presented as the mean ±SEM (\* p\<0.05 and \*\* p\<0.01 *vs.* control; ^\#^ p\<0.05 and ^\#\#^ p\<0.01 *vs.* ALD).](medscimonit-25-5375-g002){#f2-medscimonit-25-5375}

![Effects of OMT and curcumin on Collagen I, Collagen III, FN, α-SMA, CTGF, and MR induced by ALD in CFBs. CFBs were pretreated with 10 μmol/L curcumin, 1 μmol/L spironolactone (Spiro), 18.9 μmol/L OMT, or 37.8 μmol/L OMT for 2 h, and then exposed to 0.1 μmol/L ALD for 24 h. (**A**) The expression of hydroxyproline content in CFBs supernatant was determined using a commercial kit. Western blot was used to assess expression of (**B, C**) Collagen I, (**D**) Collagen III, (**E**) FN, (**F**) α-SMA, (**G**) CTGF, and (**H**) MR protein in CFBs. (**I**) Immunofluorescent staining for α-SMA (green) and nuclear marker DAPI (blue) in CFBs after indicated treatment (magnification, 200×). Results are presented as the mean ±SEM (\* p\<0.05 and \*\* p\<0.01 *vs.* control; ^\#^ p\<0.05 and ^\#\#^ p\<0.01 *vs.* ALD).](medscimonit-25-5375-g003){#f3-medscimonit-25-5375}

![OMT ameliorating ALD-induced cardiac fibrosis is involved in the Nrf2/Keap1 signaling pathway. CFBs were pretreated with 10 μmol/L curcumin, 1 μmol/L spironolactone (Spiro), 18.9 μmol/L OMT, or 37.8 μmol/L OMT for 2 h, and then exposed to 0.1 μmol/L ALD for 24 h. Western blot analysis of (**A**) Nrf2 in nuclear, (**B**) Nrf2 in cytosolic, (**C**) Keap1 in cytosolic, and (**D**) HO-1 protein expression of CFBs. (**E**) qRT-PCR analysis of the relative mRNA levels of Nrf2 in different groups. Results are presented as the mean ±SEM (\* p\<0.05 and \*\* p\<0.01 *vs.* control; ^\#^ p\<0.05 and ^\#\#^ p\<0.01 *vs.* ALD).](medscimonit-25-5375-g004){#f4-medscimonit-25-5375}

![OMT inhibited ALD-induced cardiac fibrosis depending on Nrf2 signal pathway. (**A, B**) Efficiency test of Nrf2 siRNA. Cardiac fibroblasts were transfected with negative control siRNA (NC) or Nrf2 siRNA, and the total protein of Nrf2 was determined by Western blot. Western blot analysis of (**C, D**) α-SMA, (**E**) CTGF (**F**) Collagen I, and (**G**) Collagen III protein expression in CFBs. (**H**) Immunofluorescent staining for α-SMA (green) and nuclear marker DAPI (blue) in CFBs. Results are presented as the mean ±SEM (\* p\<0.05 and \*\* p\<0.01 *vs.* control; ^\#^ p\<0.05 and ^\#\#^ p\<0.01 *vs.* ALD; ^&^ p\<0.05 *vs.* OMT+ALD).](medscimonit-25-5375-g005){#f5-medscimonit-25-5375}

![OMT and curcumin decreased oxidative stress levels in CFBs induced by ALD. CFBs were pretreated with 10 μmol/L curcumin, 1 μmol/L spironolactone (Spiro), 5 mmol/L N-acetylcysteine (NAC), 18.9 μmol/L OMT, or 37.8 μmol/L OMT for 2 h, and then exposed to 0.1 μmol/L ALD for 24 h. (**A**) Intracellular ROS were observed by fluorescence microscopy. (**B**) Quantitative analysis of intracellular ROS in CFBs by fluorometry. The expression of (**C**) MDA, (**D**) GSH, and (**E**) SOD activity were determined by respective commercially available assay kit. Results are presented as the mean ±SEM (\* p\<0.05 and \*\* p\<0.01 *vs.* control; ^\#^ p\<0.05 and ^\#\#^ p\<0.01 *vs.* ALD).](medscimonit-25-5375-g006){#f6-medscimonit-25-5375}
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